Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Arrow Greentech Ltd

ARROWGREEN
NSE
545.30
0.17%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Arrow Greentech Ltd

ARROWGREEN
NSE
545.30
0.17%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
823Cr
Close
Close Price
545.30
Industry
Industry
Plastics - Plastic & Plastic Products
PE
Price To Earnings
16.03
PS
Price To Sales
3.81
Revenue
Revenue
216Cr
Rev Gr TTM
Revenue Growth TTM
-8.73%
PAT Gr TTM
PAT Growth TTM
-16.70%
Peer Comparison
How does ARROWGREEN stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
ARROWGREEN
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
484429255166655557426156
Growth YoY
Revenue Growth YoY%
972.2265.265.8-19.85.250.7122.7121.213.2-37.1-5.81.7
Expenses
ExpensesCr
302920183538393741274037
Operating Profit
Operating ProfitCr
1914971628261816142119
OPM
OPM%
38.632.830.929.330.942.440.632.528.034.334.034.3
Other Income
Other IncomeCr
111111122222
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
222222222222
PBT
PBTCr
1813861427261816142119
Tax
TaxCr
542147754356
PAT
PATCr
139551020191311111613
Growth YoY
PAT Growth YoY%
396.5305.31,305.634.4-21.7116.3267.8162.913.6-45.8-15.43.6
NPM
NPM%
26.621.317.419.619.830.528.723.319.926.325.823.7
EPS
EPS
8.96.23.43.36.713.412.48.57.67.210.48.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
4951533534225234109149243216
Growth
Revenue Growth%
36.94.73.5-34.3-0.8-35.8137.8-35.7223.136.563.9-11.2
Expenses
ExpensesCr
191416294930444185102155146
Operating Profit
Operating ProfitCr
2937365-15-88-724468870
OPM
OPM%
60.573.368.915.5-43.6-35.415.9-21.821.631.236.332.5
Other Income
Other IncomeCr
155221322358
Interest Expense
Interest ExpenseCr
000001111000
Depreciation
DepreciationCr
112444557878
PBT
PBTCr
3041393-17-106-1118418670
Tax
TaxCr
7105300-1-26112319
PAT
PATCr
2331350-17-107-912296351
Growth
PAT Growth%
44.736.310.9-99.5-9,934.639.4166.8-235.7232.4139.2114.8-18.5
NPM
NPM%
47.261.565.80.5-49.2-46.413.0-27.511.319.825.923.8
EPS
EPS
17.724.127.10.2-13.3-8.44.5-6.68.519.641.834.0

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Sep 2025
Equity Capital
Equity CapitalCr
121212121214141415151515
Reserves
ReservesCr
355886866662706183112173197
Current Liabilities
Current LiabilitiesCr
121555698817141517
Non Current Liabilities
Non Current LiabilitiesCr
101115444346
Total Liabilities
Total LiabilitiesCr
608610610687929989121145208236
Current Assets
Current AssetsCr
30505746363142397784153185
Non Current Assets
Non Current AssetsCr
303548605161575045625651
Total Assets
Total AssetsCr
608610610687929989121145208236

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
2627175-1631231868
Investing Cash Flow
Investing Cash FlowCr
-11-6-12-138-242-2-14-13-55
Financing Cash Flow
Financing Cash FlowCr
-4-7-2-6-312-2-28-4-4
Net Cash Flow
Net Cash FlowCr
11142-14-11-82-1-319
Free Cash Flow
Free Cash FlowCr
222142-23-15-4-6-1761
CFO To PAT
CFO To PAT%
114.887.548.22,927.197.5-33.513.8-25.824.360.8107.2
CFO To EBITDA
CFO To EBITDA%
89.773.346.193.8109.9-43.911.3-32.612.738.576.5

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
449648492379944793147386577787
Price To Earnings
Price To Earnings
20.621.514.41,405.00.00.014.60.031.419.612.5
Price To Sales
Price To Sales
9.212.89.311.02.72.11.84.33.53.93.2
Price To Book
Price To Book
9.69.35.03.91.20.61.12.03.94.54.2
EV To EBITDA
EV To EBITDA
14.416.312.465.4-5.0-4.29.4-17.915.312.08.4
Profitability Ratios
Profitability Ratios
GPM
GPM%
92.795.694.076.225.044.349.042.550.160.554.0
OPM
OPM%
60.573.368.915.5-43.6-35.415.9-21.821.631.236.3
NPM
NPM%
47.261.565.80.5-49.2-46.413.0-27.511.319.825.9
ROCE
ROCE%
63.258.940.53.3-21.9-12.47.1-13.018.932.145.6
ROE
ROE%
49.145.035.60.2-21.7-13.48.1-12.412.523.133.5
ROA
ROA%
38.136.532.80.2-19.5-11.26.9-10.410.120.230.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
#### **Overview** Arrow Greentech Limited (AGTL), established in **1992**, is India’s largest manufacturer of **water-soluble films** and a globally recognized innovator in **eco-friendly materials and high-security technologies**. Headquartered in Mumbai with a core manufacturing facility in **Ankleshwar, Gujarat**, AGTL operates across two primary business segments: - **Green Products** (eco-friendly, biodegradable, and water-soluble materials) - **Hi-Tech Products** (anti-counterfeit security solutions and intellectual property-based technologies) The company has a strong global footprint through subsidiaries in the **UK, Netherlands, and other international markets**, serving clients across Europe, the Americas, Asia, and Africa. --- #### **Core Business Segments** ##### **1. Green Products Segment** AGTL’s Green Products segment focuses on sustainable, biodegradable alternatives to single-use plastics, positioning the company at the forefront of the global green revolution. - **Watersol®**: - Flagship brand of **polyvinyl alcohol (PVA) water-soluble films**. - Dissolves completely in water, leaving no residue. - Used in agrochemicals, home care, construction chemicals, laundry bags, disinfectant pouches, and hygiene products. - Agrochemical and home care sectors represent **60–70% of global demand**. - **BioPlast® Division**: - Develops **100% bio-compostable films** compliant with **EN 13432 and ISO 17088** standards. - Made from renewable materials like **potato starch and polylactic acid (PLA)**. - Applications include garbage bags, food packaging, disposable tableware, and industrial containers. - Technology licensed from **Biotec, Germany**. - **KlenzPro**: - Offers **concentrated hygiene products in water-soluble capsules**, eliminating plastic waste. - **Sustainability & Growth Prospects**: - The **global PVA films market** was valued at ~$550 million in 2024, projected to grow at **5–6% CAGR through 2030**. - Driven by rising environmental regulations and consumer demand for sustainable packaging. - AGTL is a pioneer in **eco-industrial solutions**, aligning with **Atma Nirbhar Bharat and Make in India** initiatives. ##### **2. Hi-Tech & Security Products** AGTL is a leader in **anti-counterfeit technologies**, serving the currency, pharmaceutical, luxury goods, and government documentation sectors. - **Key Offerings**: - **Security Threads & Fibers**: For integration into **banknotes, passports, tax stamps, and ID cards**. - **Dual-Color Shift Security Film**: Patented US and Indian technology (US Patent No. 12,194,771 granted Jan 2025) that changes color when viewed from different angles—ideal for high-security documents. - **Security Laminates**: Multi-layered, machine-readable, track-and-trace enabled films for **Aadhaar, voter IDs, and pharmaceutical packaging**. - **Self-Destructive Security Packaging**: Prevents tampering and counterfeiting. - **Level 2 Brand Protection**: Applied to high-value consumer goods (cosmetics, perfumes, pharma). - **Manufacturing Capabilities**: - Advanced processes including **metalizing, holography, nano-printing, and functional coatings**. - Contractually confidential clients; considered a trusted indigenous supplier in a niche global market. --- #### **Pharmaceutical Innovation via Subsidiary: Avery Pharmaceuticals Pvt. Ltd.** AGTL owns **99.65% of Avery Pharmaceuticals**, a WHO-GMP, FSSAI, HALAL, and ISO 9001/22000 certified subsidiary manufacturing **Mouth Dissolving Strips (MDS)** and **Transdermal Patches**. - **Arrow RX / MDS (Mouth Dissolving Strips)**: - Commercialized under **Arrow RX**, an innovative **Novel Drug Delivery System (NDDS)**. - Patented **"Actives Embedded Water-Soluble Film"** technology enables: - Rapid onset of action (via **lingual, sublingual, or buccal absorption**). - Enhanced bioavailability. - No need for water—ideal for **pediatric, geriatric, psychiatric, dysphagic, and veterinary patients**. - Regulatory approvals for **~50 products**, including **Sildenafil, Ondansetron, Amlodipine, and vitamin/mineral formulations**. - FSSAI approvals for nutraceuticals and RX approvals for pharma products. - **Operations**: - Manufacturing plant in **Sanand, Gujarat**. - **Commercial production began August 2022**. - Equipped with German-engineered machinery for precision film casting. - Full in-house R&D, QC labs, and automated production lines. - **CDMO (Contract Development & Manufacturing Organization) Services**: - Provides end-to-end services from **formulation development to commercial-scale manufacturing**. - Signed long-term export contract with a **major MNC**, with repeat orders and pipeline expansion. - Engaged in **54 CDMO projects**, including for markets such as **Brazil, Russia, Vietnam, and Yemen**. - Active pipeline of **high-dose MDS (over 100mg)** and **combination products**. - **Other Products**: - **RX Matrix**: A patented system for **collection, storage, and disposal of biological samples**. - **Transdermal Patches**: For sustained, controlled drug delivery—under development and commercial partnerships. --- #### **Intellectual Property & Innovation** AGTL maintains a **robust IP strategy** central to its competitive advantage. - **Patents**: - **23–32 granted patents globally** (number varies by report date; most recent consensus indicates **23 in force**, but earlier reports cite up to 34). - Jurisdictions: **India, USA, UK, Europe, Russia, South Africa, Eurasia**. - **Key Patented Technologies**: - Cold water-soluble films. - Actives-embedded MDS. - Dual-color shift security film. - Self-adhesive liner-less labels (eliminates silicone liners). - Bio-compostable multi-layer composites (Indian Patent No. 497320). - Medicated wound care bands (Indian Patent No. 537781). - Water-soluble cleaning sponges and wall papers. - **Pending Applications**: - **15+ Indian and 4–13 foreign patent applications** under review. - Filed via **PCT for international protection**. - **IP Commercialization**: - Revenue generated through **out-licensing, cross-licensing, and infringement settlements**. - **Active litigation** against **Nu-Therapeutics and Shilpa Pharmaceuticals** for patent infringement. - Dedicated **IP Cells in India, UK, and Netherlands**. - **R&D Infrastructure**: - State-of-the-art **R&D lab and IP center in Mumbai**. - Collaborations with **academic institutions, inventors, and scientific communities**. - Focus on **green tech, security, healthcare, and biocompostable materials**. --- #### **Global Operations & Subsidiaries** AGTL operates internationally with strategic subsidiaries: | Subsidiary | Ownership | Location | Focus | |----------|---------|--------|-------| | **Avery Pharmaceuticals Pvt. Ltd.** | 99.65% | India | MDS, CDMO, Transdermal Patches | | **Advance IP Technologies Ltd.** | 95% | UK | IP monetization, out-licensing | | **Advance Secure Products B.V.** | 100% | Netherlands | Security product trade, EU market access | | **Arrow UK** | 100% | UK | Patent trading, film export | | **LQ Arrow Security Products Pvt. Ltd.** | 51% | India | Security systems and brand protection | | **Arrow Secure Technology Pvt. Ltd.** | 100% | India | High-tech security R&D and manufacturing | --- #### **Financial Highlights (as of Nov 2025)** - **Green Products Segment**: ₹123 million revenue — demonstrates growing market traction for sustainable solutions. - **Hi-Tech Segment**: ₹488 million revenue — driven by rising global demand for anti-counterfeit and authentication technologies. - **Export Growth**: Increasing exports to **Brazil, South America, Africa, and EU/EEA regions**, with negligible USA exports currently. - **Revenue Diversification**: Strong growth in **MDS, security products, and water-soluble capsules**. --- #### **Leadership & Recognition** - **Shilpan P. Patel** (Chairman & MD): - Invented India’s first water-soluble film in **1990** through indigenous R&D. - Holds multiple patents; awarded **India Star Award (2000)** and **National IP Award for Patents & Commercialization**. - **Neil Patel** (Joint Managing Director): Oversees operations and governance. - **Prashant Mehta** (Independent Director): Legal and corporate governance expert. - **Awards & Recognition**: - **National IP Awards (2019, 2021)** from CII. - Member of **CII-DIPPIT Select Committee on IP**, supporting national innovation policy.